Microbix Biosystems Inc. (MBX.TO)
| Previous Close | 0.7400 |
| Open | 0.7300 |
| Bid | 0.7200 x 0 |
| Ask | 0.7400 x 0 |
| Day's Range | 0.7200 - 0.7400 |
| 52 Week Range | 0.3500 - 0.7900 |
| Volume | |
| Avg. Volume | 142,398 |
| Market Cap | 80.991M |
| Beta (5Y Monthly) | 0.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0510 |
| Earnings Date | Feb. 11, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sep. 02, 1999 |
| 1y Target Est | 1.70 |
- Simply Wall St.
Microbix Biosystems (TSE:MBX) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
- GlobeNewswire
Microbix Expands Pandemic Test Controls (QAPs™) Portfolio
Helping Ensure Workflow Accuracy of PCR Tests for COVID “Variants of Concern”MISSISSAUGA, Ontario, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include controls that support PCR tests for each of the four major variants of concern (“VOCs”) of the SARS-CoV-2 virus that is the cause of the COVID-19 pandemic. Specifically, Mi
- GlobeNewswire
Microbix Receives $2.7 Million from Exercise of Warrants
Further Capital to Assist with Increasing Capacity and EfficiencyMISSISSAUGA, Ontario, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has received C$ 2.7 million from the partial exercise of two series of expiring share purchase warrants. The first series of such warrants were issued in connection with a private placement undertaken in October, 2015, and had an exercise price of C$ 0.55 and
